Zimmer Biomet (ZBH) PT Lowered to $121 at Citi
Tweet
Share
E-mailGet Alerts ZBH Hot Sheet
Price: $101.58 +2.19%
Rating Summary:
18 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Rating Summary:
18 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Join SI Premium – FREE
Citi lowered its price target on Zimmer Biomet (NYSE: ZBH) to $121.00 (from $132.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Braze Inc (BRZE) PT Raised to $40 at DA Davidson
- Zimmer Biomet Holdings (ZBH) Declares $0.24 Quarterly Dividend; 1% Yield
- Credo Tech (CRDO) PT Lowered to $310 at JPMorgan, Overweight Rating Maintained
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
